The compound has been investigated from the patent literature for its anxiolytic Houses and diminished sedative, hypnotic, and ataxic aspect-effects, but it doesn't appear to be accredited for professional medical use. ?ukasik-G?ebocka et alAn individual pharmacokinetics review showed that a dose of 0.five mg flubromazolam induced potent sedative e